| 1 |
33807929 | The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects. | 2021 Mar 5 |
3 |
| 2 |
30712667 | The Angiotensin II type 1 receptor mediates the effects of low oxygen on early placental angiogenesis. | 2019 Jan |
2 |
| 3 |
31652041 | Mid-dose losartan mitigates diabetes-induced hepatic damage by regulating iNOS, eNOS, VEGF, and NF-κB expressions | 2019 Oct 24 |
3 |
| 4 |
26045756 | Local renin-angiotensin system regulates hypoxia-induced vascular endothelial growth factor synthesis in mesenchymal stem cells. | 2015 |
1 |
| 5 |
25014541 | Dual targeting of angiotensin receptors (AGTR1 and AGTR2) in epithelial ovarian carcinoma. | 2014 Oct |
1 |
| 6 |
23092556 | Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer. | 2013 Jan 28 |
1 |
| 7 |
22188725 | Inhibition of the renin-angiotensin system downregulates tissue factor and vascular endothelial growth factor in human breast carcinoma cells. | 2012 Jun |
1 |
| 8 |
17299153 | ACE inhibitor and AT1-receptor blocker attenuate the production of VEGF in mesothelial cells. | 2007 Mar-Apr |
2 |
| 9 |
17481528 | Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma. | 2007 May |
1 |
| 10 |
16764023 | [Protective effect of losartan on endothelial cells exposed to high glucose levels in vitro]. | 2006 May |
2 |
| 11 |
15610240 | Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy. | 2005 Jan |
1 |
| 12 |
11942316 | Losartan attenuates endothelial hyperpermeability responses to VPF and high glucose but not angiotensin II. | 2002 Feb |
1 |
| 13 |
12208167 | Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. | 2002 Sep |
1 |
| 14 |
11523316 | Effect of short-term losartan treatment in patients with primary aldosteronism and essential hypertension. | 2001 Apr |
2 |
| 15 |
10215323 | Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. | 1999 Feb |
3 |
| 16 |
7737726 | Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. | 1995 May |
1 |